Daily Bulletin

The Conversation

  • Written by The Conversation Contributor

Taxol is a chemotherapy drug used in the treatment of specific human cancers. It is a member of the taxane family of drugs, which includes cabazitaxel and docetaxel.

The drug is also sold under its generic name of paclitaxel (pronounced pack-lee-tax-elle). Taxol is available by prescription only and is administered via an intravenous injection in a hospital setting. The dose each patient is administered is calculated taking into account their underlying health, height and weight.

image CC BY-ND


Arthur Barclay was a botanist working for the US Department of Agriculture in the 1960s. Under contract to the US National Cancer Institute, Barclay collected samples of plants to find new drugs.

The National Cancer Institute screened 35,000 plants. One particular sample Barclay collected, the bark of the Pacific Yew tree, went on to provide what is now one of the most highly prescribed chemotherapy drugs for cancer.

Taxol, which is a chemical extracted from the bark, was selected for commercial development in 1977 and was first tested in patients in 1984. It was approved for use by the US Food and Drug administration in 1992 and by 2000 had annual sales of A$2.1 billion per year.

The drug’s name is derived from the Latin term for the tree, Taxus brevifolia.

How it works

Every cell in the body has long rod-like structures, which scientists call microtubules. These microtubules have several functions, one of which is to act like a type of skeleton structure that helps give cells their shape.

When cells replicate, they break down this skeleton, divide into two cells, then rebuild it. Taxol acts by promoting the formation of these microtubules, which means they get in the way when the cells try to divide.

Preventing cells from replicating sends them into a process of programmed cell death called apoptosis, which kills the tumour.

Who is administered Taxol?

Taxol is used in combination with other chemotherapy drugs and surgery. In Australia, it is used to treat ovarian, breast, cervical, endometrial and non-small cell lung cancers.

It is also used to treat AIDS-related Kaposi’s sarcoma, a rare type of cancer that develops as tumours on the skin and inside the mouth.

Problems with the drug

The biggest problem of Taxol is its poor solubility in water. Water solubility is important because a drug must be fully dissolved to be safe for injection. Any solid particles in an intravenous injection can lead to blood clots and inflammation of the veins.

Because of this, Taxol is typically dissolved in alcohol with the addition of a soap-like chemical called polyoxyethylated 35 castor oil (also referred to as Chremophor EL).

A new formulation of protein-bound Taxol called abraxane is available in Australia. In this formulation, Taxol is combined with albumin, the most abundant protein in human blood serum. Binding the drug to the protein makes it take on the albumin’s solubility, and it can then be administered to patients in water-based formulations.


The Pacific Yew tree grows only in the northwest region of America. It is slow growing and found only in old-growth forests.

In the early days of the drug’s development, the bark was obtained from the tree by logging, which killed the trees. This meant supply of the drug was limited and the process was nonrenewable and not environmentally friendly. At least one kilogram of bark was required to produce just 10 grams of drug.

Thankfully, while the drug cannot yet be completely synthesised in a factory, chemists have developed ways to produce it using precursor chemicals found in the needles of a related tree, Taxus baccata.

They can also manufacture the drug by culturing plant cells. This latter process is renewable and can produce up to 50 grams of drug per kilogram of plant material.

Side effects

Like all chemotherapy drugs, Taxol has some common side effects, which many patients experience. These include the production of fewer blood cells, which can make patients anaemic and susceptible to infections; nausea; vomiting; diarrhoea; hair loss; muscle and joint pain; nerve problems, which include weakness, tingling, pain or numbness in the hands or feet; and changes in heart rate and blood pressure.

These side effects can be managed by giving the patient additional medicines or by adjusting the dose of the drug.

Taxol also has another side effect that can be life-threatening. Some patients experience a severe allergic reaction the first time they are given the drug. This is due to the Chremophor EL included in the formulation.

In these cases, the doctor may give the patient a different taxane drug, use albumin-bound Taxol instead, or develop a plan to desensitise the patient to Taxol.


Whether a patient is charged for this drug depends on how the hospital classifies them. Anyone classified as a public in-patient will be not be charged for Taxol as its cost will be covered under Medicare.

Anyone classified as a public out-patient will be charged at a maximum rate of A$38.30 per treatment.

Under a special arrangement, the price the government pays for the albumin-bound formulation of Taxol depends on the type of cancer it is being used to treat and costs between A$1,287 to A$2,562 for 275 mg of the drug.

In contrast, the normal Taxol formulation is much cheaper, although less safe, for the government at A$222.90 for 450 mg of the drug.

Information provided in this article is based primarily on the Australian Medicines Handbook 2016. If you would like more information, the patient information sheet on Taxol is available here.

Authors: The Conversation Contributor

Read more http://theconversation.com/weekly-dose-taxol-the-anticancer-drug-discovered-in-the-bark-of-a-tree-56508

Writers Wanted

Why this Queensland election is different — states are back at the forefront of political attention


Cervical, breast, heart, bowel: here’s what women should be getting screened regularly


Will I or won't I? Scientists still haven't figured out free will, but they're having fun trying


The Conversation


Prime Minister Interview with Kieran Gilbert, Sky News

KIERAN GILBERT: Kieran Gilbert here with you and the Prime Minister joins me. Prime Minister, thanks so much for your time.  PRIME MINISTER: G'day Kieran.  GILBERT: An assumption a vaccine is ...

Daily Bulletin - avatar Daily Bulletin

Did BLM Really Change the US Police Work?

The Black Lives Matter (BLM) movement has proven that the power of the state rests in the hands of the people it governs. Following the death of 46-year-old black American George Floyd in a case of ...

a Guest Writer - avatar a Guest Writer

Scott Morrison: the right man at the right time

Australia is not at war with another nation or ideology in August 2020 but the nation is in conflict. There are serious threats from China and there are many challenges flowing from the pandemic tha...

Greg Rogers - avatar Greg Rogers

Business News

AppDynamics Solves Visibility Gap Between Traditional Infrastructure and Cloud Environments

New Full Stack Observability Platform, Integration With Cisco Intersight Workload Optimizer and Cloud Native Visualisation Features Provide Cross Domain Insights and Analytics of Business Perfor...

Hotwire Global - avatar Hotwire Global

Why Your Small Business Should Bulk Buy Hand Sanitiser

As a small business owner, employee and customer safety is at the very top of your priority list. From risk assessments to health and safety officers, appropriate signage and proper briefing...

News Co - avatar News Co

How Phone Number Search In Sydney Can Help Your Business

To run a successful business, keeping track of your company and competitors are the major factors. With a lot of tools, available businesses have options to stay current. One way in which busine...

News Co - avatar News Co

News Co Media Group

Content & Technology Connecting Global Audiences

More Information - Less Opinion